|
Jun 19
|
QIAGEN's (QGEN) New QCI Interpret Release Enhances AI Functions
|
|
Jun 17
|
QIAGEN (QGEN) Debuts dPCR Microbial DNA Detection Assays
|
|
Jun 17
|
QIAGEN announces 2028 strategy for solid profitable growth
|
|
Jun 13
|
QIAGEN’s software QCI Interpret accelerates clinical reporting turnaround time for high throughput NGS testing labs
|
|
Jun 12
|
QIAGEN publishes 2023 sustainability report, highlighting progress on ESG goals and commitment to sustainable growth
|
|
Jun 11
|
QIAGEN launches new QIAcuity digital PCR assays for microbial applications, enhancing infectious disease research and surveillance
|
|
May 29
|
QIAGEN launches new library preparation kit, facilitating multiomic studies and advancing precision medicine
|
|
May 29
|
Qiagen (QGEN) Up 1.6% Since Last Earnings Report: Can It Continue?
|
|
May 22
|
Estimating The Fair Value Of Qiagen N.V. (NYSE:QGEN)
|
|
May 15
|
QIAGEN's (QGEN) QCI Interpret Gets European IVDR Certification
|
|
May 14
|
QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical device software for clinical decision support
|
|
May 14
|
QIAGEN (QGEN) Wins FDA Nod for QIAstat-Dx Respiratory Panel Plus
|
|
May 13
|
QIAGEN (QGEN) to Enhance Forensics With New Partnership
|
|
May 13
|
Qiagen’s QIAstat-Dx respiratory diagnostic wins FDA clearance
|
|
May 13
|
QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accurate results
|
|
May 8
|
Qiagen and FBI partner on DNA quant digital PCR assays
|
|
May 7
|
QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensics
|
|
May 6
|
International Markets and Qiagen (QGEN): A Deep Dive for Investors
|
|
May 2
|
QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inherited disease applications
|
|
May 2
|
Qiagen N.V. Just Recorded A 6.9% EPS Beat: Here's What Analysts Are Forecasting Next
|